buy in the low 20s, page-5

A TO price @ $1.50 eqautes to a market cap of around $460m. Is that a reasonable valuation? All depends on the number of implants VCR and the LVAD industry can generate going forward.

To date, as previously mentioned, the EU sales have been very poor. We know there's a demand but the uptake is very very slow. It will take plenty of time for doctors/surgeons/hospitals to switch devices or undertake this kind of therapy.

There is a lot to consider but I do think there is an opportunity for some real profit both from the SP perspective and from the companies perspective.

Fastrack the TETS device !!